Spots Global Cancer Trial Database for oncology patients
Every month we try and update this database with for oncology patients cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas | NCT01231347 | Adenocarcinoma ... Advanced Solid ... Cancer Cancer of Pancr... Cancer of the P... Metastases Metastatic Canc... Metastatic Panc... Pancreas Cancer Pancreatic Canc... Bone Metastases Endocrine Cance... Oncology Oncology Patien... Solid Tumors Advanced Malign... | AMG 479 Placebo AMG 479 gemcitabine | 18 Years - | NantCell, Inc. | |
| A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia | NCT02016729 | Advanced Malign... Cancer Oncology Oncology Patien... Acute Myeloid L... | AMG 232 Trametinib | 18 Years - | Kartos Therapeutics, Inc. | |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma | NCT01723020 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors Glioblastoma Multiple Myelom... | AMG 232 | 18 Years - | Kartos Therapeutics, Inc. | |
| Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients | NCT02645357 | Medical Oncolog... | computer remind... Control group | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic | NCT04406844 | Oncology Patien... | 12 Years - 98 Years | Max Healthcare Insititute Limited | ||
| A Study to Look at How a Single Oral Dose of 14C-OSI-906 is Absorbed, Broken Down and Eliminated in the Body | NCT01529684 | Advanced Solid ... Pharmacokinetic... | radio-labeled O... OSI-906 | 18 Years - | Astellas Pharma Inc | |
| A Study of AMG 337 in Subjects With Advanced Solid Tumors | NCT01253707 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 337 | 18 Years - | Amgen | |
| AMG 319 Lymphoid Malignancy FIH | NCT01300026 | Cancer Chronic Lymphoc... Diffuse Large C... Hematologic Mal... Hematology Leukemia Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Oncology Oncology Patien... T Cell Lymphoma Tumors | AMG 319 | 18 Years - | Amgen | |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors | NCT01444404 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 820 | 18 Years - | AmMax Bio, Inc. | |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors | NCT01444404 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 820 | 18 Years - | AmMax Bio, Inc. | |
| Implementing an Evidence-based Computerized Decision Support System Linked to Electronic Health Records to Improve Care for Cancer Patients | NCT02645357 | Medical Oncolog... | computer remind... Control group | 18 Years - | Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori | |
| A Study of AMG 820 in Subjects With Advanced Solid Tumors | NCT01444404 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors | AMG 820 | 18 Years - | AmMax Bio, Inc. | |
| A Phase 1b Study Evaluating AMG 232 Alone and in Combination With Trametinib in Acute Myeloid Leukemia | NCT02016729 | Advanced Malign... Cancer Oncology Oncology Patien... Acute Myeloid L... | AMG 232 Trametinib | 18 Years - | Kartos Therapeutics, Inc. | |
| A Phase 1 Dose Escalation Study of AMG 780 in Adult Subjects With Advanced Solid Tumors | NCT01137552 | Advanced Solid ... | AMG 780 | 18 Years - | Amgen | |
| Issues and Challenges in Cancer Patients on Active Treatment During the COVID-19 Pandemic | NCT04406844 | Oncology Patien... | 12 Years - 98 Years | Max Healthcare Insititute Limited | ||
| AMG 319 Lymphoid Malignancy FIH | NCT01300026 | Cancer Chronic Lymphoc... Diffuse Large C... Hematologic Mal... Hematology Leukemia Low Grade Lymph... Lymphoma Mantle Cell Lym... Non-Hodgkin's L... Oncology Oncology Patien... T Cell Lymphoma Tumors | AMG 319 | 18 Years - | Amgen | |
| A Phase 1 Study Evaluating AMG 232 in Advanced Solid Tumors or Multiple Myeloma | NCT01723020 | Advanced Malign... Advanced Solid ... Cancer Oncology Oncology Patien... Tumors Glioblastoma Multiple Myelom... | AMG 232 | 18 Years - | Kartos Therapeutics, Inc. |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
